Cargando…
Hypermethylated promoters of tumor suppressor genes were identified in Crohn’s disease patients
BACKGROUND/AIMS: Overwhelming evidence suggests that inflammatory bowel disease (IBD) is caused by a complicated interplay between the multiple genes and abnormal epigenetic regulation in response to environmental factors. It is becoming apparent that epigenetic factors are significantly associated...
Autores principales: | Kim, Tae-Oh, Han, Yu Kyeong, Yi, Joo Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385571/ https://www.ncbi.nlm.nih.gov/pubmed/32019290 http://dx.doi.org/10.5217/ir.2019.00105 |
Ejemplares similares
-
Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC)
por: Kim, Soo Yeon, et al.
Publicado: (2019) -
A Genome-Wide Methylation Approach Identifies a New Hypermethylated Gene Panel in Ulcerative Colitis
por: Kang, Keunsoo, et al.
Publicado: (2016) -
Promoter Hypermethylation of Tumour Suppressor Genes as Potential Biomarkers in Colorectal Cancer
por: Ng, Jennifer Mun-Kar, et al.
Publicado: (2015) -
Promoter hypermethylation of tumor suppressor genes correlates with tumor grade and invasiveness in patients with urothelial bladder cancer
por: Bilgrami, Shumaila M, et al.
Publicado: (2014) -
Genome-Wide Analysis of the DNA Methylation Profile Identifies the fragile histidine triad (FHIT) Gene as a New Promising Biomarker of Crohn’s Disease
por: Kim, Tae-Oh, et al.
Publicado: (2020)